Maria Lucia Brun-Vergara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Lucia Brun-Vergara has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Carlos H. Torres
Department of Radiology, Radiation Oncology and Medical Physics, 501 Smyth Road, Box #232, Ottawa, ON K1H8L6, Canada
3 shared publications- Julia Niemierko
Gdansk Medical University, Gdansk, Pomerania, Poland
3 shared publications - Melina Hosseiny
Department of Radiology, University of California–San Diego, 9300 Campus Point Dr, MC 0841, La Jolla, CA 92037-0841
3 shared publications - Nader Zakhari
Department of Radiology, Radiation Oncology and Medical Physics The Ottawa Hospital|University of Ottawa Ottawa Ontario Canada
3 shared publications - Anisha Bhagwanani
Department of Radiology, Frimley Health NHS Foundation Trust, Frimley Park Hospital, Surrey, UK
2 shared publications - Antariksh Vijan
Department of Radiodiagnosis, Tata Memorial Centre, Mumbai, India
2 shared publications
Latest Publications
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (9)
Imaging Review and Clinical Manifestations of Lacunar Stroke Syndromes
Imaging plays a crucial role in diagnosis of classic and atypical lacunar syndromes, and detection of acute lacunar infarcts can be improved with correlation of clinical and radiologic features.
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (9)
Imaging Review and Clinical Manifestations of Lacunar Stroke Syndromes
Imaging plays a crucial role in diagnosis of classic and atypical lacunar syndromes, and detection of acute lacunar infarcts can be improved with correlation of clinical and radiologic features.
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (9)
Integrating Humanism and Ethics into Radiology Training: Building Resilient, Reflective, Patient-centered Physicians
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (9)
Integrating Humanism and Ethics into Radiology Training: Building Resilient, Reflective, Patient-centered Physicians
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250137
Radiology Residency Around the World: A Global Comparison
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250137
Radiology Residency Around the World: A Global Comparison
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (4) , e250057
The Final Sign: Advice for Transitioning from Radiology Training to Independent Practice
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (4) , e250057
The Final Sign: Advice for Transitioning from Radiology Training to Independent Practice
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (1) , e250004
Planning Ahead: Residents’ Guide to Building a Strong Financial Future
- 1 January 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (1) , e250004
Planning Ahead: Residents’ Guide to Building a Strong Financial Future
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (12) , e250191
Amyloidoma
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (12) , e250191
Amyloidoma
- Open Access
- 25 October 2025
- Published by Springer Nature in Insights into Imaging
- Vol. 16 (1) , 1-15
Pathology of the conus medullaris and cauda equina. Beyond the usual suspects
Background: Pathologies affecting the conus medullaris and cauda equina can present with overlapping clinical symptoms, making an accurate diagnosis essential. Conus medullaris syndrome results from damage at the T12–L2 level, while cauda equina syndrome arises from nerve root compression below the conus. Both conditions may cause motor deficits, sensory disturbances, and autonomic dysfunction, necessitating a detailed differential diagnosis. Objective: This educational review highlights common and rare etiologies of conus medullaris and cauda equina lesions, emphasizing imaging characteristics and diagnostic considerations. A comprehensive review of tumors, infections, inflammatory, vascular, and degenerative conditions affecting these regions was performed. Contrast-enhanced MRI was identified as the gold standard for diagnosis. Revised pathologies: Tumors: myxopapillary ependymomas and schwannomas are the most frequent neoplasms, while drop metastases and glioblastomas represent rarer entities. Infections: tuberculous arachnoiditis, bacterial radiculitis, schistosomiasis, and neurocysticercosis may mimic neoplastic processes. Inflammatory disorders: Guillain–Barré syndrome, neurosarcoidosis, and MOGAD may cause nerve root thickening and enhancement. Vascular lesions: spinal dural arteriovenous fistulas, infarcts, and arteriovenous malformations can produce conus and cauda equina symptoms. Miscellaneous causes: developmental anomalies like diastematomyelia and ventriculus terminalis, along with degenerative diseases, can mimic other conditions. Conclusion: Radiologists play a pivotal role in differentiating conus medullaris and cauda equina pathologies. A thorough understanding of imaging findings is essential for accurate diagnosis and effective management. Critical relevance statement: Conus medullaris and cauda lesions present with overlapping clinical symptoms but show some distinct imaging patterns. It is essential to recognize characteristic features that differentiate neoplastic from infectious or vascular etiologies. Key Points: Conus and cauda lesions have varied causes; MRI with contrast is vital for accurate diagnosis. Myxopapillary ependymomas cause vertebral scalloping; schwannomas may be cystic; intramedullary gliomas expand the cord. Conus medullaris and cauda lesions overlap clinically; imaging helps distinguish neoplastic from infectious or vascular causes. Graphical
- 25 October 2025
- Published by Springer Nature in Insights into Imaging
- Vol. 16 (1) , 1-15
Open AccessPathology of the conus medullaris and cauda equina. Beyond the usual suspects
Background: Pathologies affecting the conus medullaris and cauda equina can present with overlapping clinical symptoms, making an accurate diagnosis essential. Conus medullaris syndrome results from damage at the T12–L2 level, while cauda equina syndrome arises from nerve root compression below the conus. Both conditions may cause motor deficits, sensory disturbances, and autonomic dysfunction, necessitating a detailed differential diagnosis. Objective: This educational review highlights common and rare etiologies of conus medullaris and cauda equina lesions, emphasizing imaging characteristics and diagnostic considerations. A comprehensive review of tumors, infections, inflammatory, vascular, and degenerative conditions affecting these regions was performed. Contrast-enhanced MRI was identified as the gold standard for diagnosis. Revised pathologies: Tumors: myxopapillary ependymomas and schwannomas are the most frequent neoplasms, while drop metastases and glioblastomas represent rarer entities. Infections: tuberculous arachnoiditis, bacterial radiculitis, schistosomiasis, and neurocysticercosis may mimic neoplastic processes. Inflammatory disorders: Guillain–Barré syndrome, neurosarcoidosis, and MOGAD may cause nerve root thickening and enhancement. Vascular lesions: spinal dural arteriovenous fistulas, infarcts, and arteriovenous malformations can produce conus and cauda equina symptoms. Miscellaneous causes: developmental anomalies like diastematomyelia and ventriculus terminalis, along with degenerative diseases, can mimic other conditions. Conclusion: Radiologists play a pivotal role in differentiating conus medullaris and cauda equina pathologies. A thorough understanding of imaging findings is essential for accurate diagnosis and effective management. Critical relevance statement: Conus medullaris and cauda lesions present with overlapping clinical symptoms but show some distinct imaging patterns. It is essential to recognize characteristic features that differentiate neoplastic from infectious or vascular etiologies. Key Points: Conus and cauda lesions have varied causes; MRI with contrast is vital for accurate diagnosis. Myxopapillary ependymomas cause vertebral scalloping; schwannomas may be cystic; intramedullary gliomas expand the cord. Conus medullaris and cauda lesions overlap clinically; imaging helps distinguish neoplastic from infectious or vascular causes. Graphical
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (6) , e240228
The Clinician-Scientist Radiology Residency Pathway: Cultivating Leaders in Radiology Research and Innovation
- 1 June 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (6) , e240228
The Clinician-Scientist Radiology Residency Pathway: Cultivating Leaders in Radiology Research and Innovation
- Open Access
- 24 February 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2480-2488
Diagnostic Accuracy of 1H‐MRS Using PRESS and MEGA‐PRESS Techniques in the Preoperative Grading of Patients With Gliomas
Background: Edited MRS technique such as MEshcher‐GArwood Point RESolved Spectroscopy (MEGA‐PRESS) can determine isocitrate dehydrogenase mutation (IDH) mutation status in patients with gliomas but its accuracy in assessing glioma grade has not yet been formally evaluated.Purpose: To evaluate the diagnostic accuracy of metabolites such as lactate obtained from the PRESS and MEGA‐PRESS sequences in the preoperative grading of glioma. To assess the prognostic value of those metabolite ratios in the overall survival of patients with gliomas.Study Type: Prospective.Subjects: Sixty‐nine subjects with gliomas (16 grade 2, 21 grade 3, and 32 grade 4). Mean age was 50.5 ± 16.7 years; 38 were male and 31 were female.Field Strength/Sequence: 3 T/MEGA‐PRESS, PRESS.Assessment: Single voxel PRESS and MEGA‐PRESS spectra were obtained from tumors in patients undergoing preoperative MRI. Several tumor metabolites were measured from the PRESS, MEGA‐PRESS edit‐off, and difference spectra using LCModel (Linear Combination of Model Spectra) software. Diagnosis and glioma grading was done using the World Health Organization (WHO) 2016 classification. Overall survival was assessed.Statistical Tests: Diagnostic accuracy was measured using receiver‐operating characteristic (ROC) curve. Univariate and multivariate Cox proportional hazards modeling was used for the assessment of prognostic factors for time to death.Results: In the differentiation between low‐ vs. high‐grade gliomas, tCr/tCho ratios obtained from PRESS and MEGA‐PRESS sequences had similar accuracies (area under the ROC curves [AUCs] = 0.71) while Lac/NAA from PRESS had a lower accuracy (AUC = 0.65). The presence of a detectable 2‐hydroxyglutarate peak on the difference spectrum was a favorable prognostic factor in univariate analysis (hazard ratio = 0.25, 95% confidence interval: 0.08–0.83). No other metabolite was found to be a significant prognostic factor in univariate and multivariate analyses.Data Conclusion: Edited MRS can be used to detect metabolites which can help in the preoperative grading of gliomas and in determination of the overall survival. A separate PRESS acquisition is needed for lactate quantification.Plain Language Summary: Gliomas are brain tumors that vary in severity. This study explored the use of two advanced MR spectroscopy techniques (PRESS and MEGA‐PRESS) in detecting tumor metabolites. The authors found that both techniques' choline/creatine ratio showed moderate accuracy in identifying high‐grade gliomas. Lactate was better revealed with the PRESS technique and was associated with high‐grade gliomas. They confirmed that the MEGA‐PRESS technique allowed additional detection of 2‐hydroxyglutarate in IDH‐mutant gliomas, which was linked to better survival. These findings emphasize that advanced MR spectroscopy can extract metabolic information time‐efficiently, which can be used to improve the preoperative diagnosis of patients with gliomas.Level of Evidence: 1Technical Efficacy: Stage 2
- 24 February 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 61 (6) , 2480-2488
Open AccessDiagnostic Accuracy of 1H‐MRS Using PRESS and MEGA‐PRESS Techniques in the Preoperative Grading of Patients With Gliomas
Background: Edited MRS technique such as MEshcher‐GArwood Point RESolved Spectroscopy (MEGA‐PRESS) can determine isocitrate dehydrogenase mutation (IDH) mutation status in patients with gliomas but its accuracy in assessing glioma grade has not yet been formally evaluated.Purpose: To evaluate the diagnostic accuracy of metabolites such as lactate obtained from the PRESS and MEGA‐PRESS sequences in the preoperative grading of glioma. To assess the prognostic value of those metabolite ratios in the overall survival of patients with gliomas.Study Type: Prospective.Subjects: Sixty‐nine subjects with gliomas (16 grade 2, 21 grade 3, and 32 grade 4). Mean age was 50.5 ± 16.7 years; 38 were male and 31 were female.Field Strength/Sequence: 3 T/MEGA‐PRESS, PRESS.Assessment: Single voxel PRESS and MEGA‐PRESS spectra were obtained from tumors in patients undergoing preoperative MRI. Several tumor metabolites were measured from the PRESS, MEGA‐PRESS edit‐off, and difference spectra using LCModel (Linear Combination of Model Spectra) software. Diagnosis and glioma grading was done using the World Health Organization (WHO) 2016 classification. Overall survival was assessed.Statistical Tests: Diagnostic accuracy was measured using receiver‐operating characteristic (ROC) curve. Univariate and multivariate Cox proportional hazards modeling was used for the assessment of prognostic factors for time to death.Results: In the differentiation between low‐ vs. high‐grade gliomas, tCr/tCho ratios obtained from PRESS and MEGA‐PRESS sequences had similar accuracies (area under the ROC curves [AUCs] = 0.71) while Lac/NAA from PRESS had a lower accuracy (AUC = 0.65). The presence of a detectable 2‐hydroxyglutarate peak on the difference spectrum was a favorable prognostic factor in univariate analysis (hazard ratio = 0.25, 95% confidence interval: 0.08–0.83). No other metabolite was found to be a significant prognostic factor in univariate and multivariate analyses.Data Conclusion: Edited MRS can be used to detect metabolites which can help in the preoperative grading of gliomas and in determination of the overall survival. A separate PRESS acquisition is needed for lactate quantification.Plain Language Summary: Gliomas are brain tumors that vary in severity. This study explored the use of two advanced MR spectroscopy techniques (PRESS and MEGA‐PRESS) in detecting tumor metabolites. The authors found that both techniques' choline/creatine ratio showed moderate accuracy in identifying high‐grade gliomas. Lactate was better revealed with the PRESS technique and was associated with high‐grade gliomas. They confirmed that the MEGA‐PRESS technique allowed additional detection of 2‐hydroxyglutarate in IDH‐mutant gliomas, which was linked to better survival. These findings emphasize that advanced MR spectroscopy can extract metabolic information time‐efficiently, which can be used to improve the preoperative diagnosis of patients with gliomas.Level of Evidence: 1Technical Efficacy: Stage 2
- 22 February 2025
- Published by Elsevier in Magnetic Resonance Imaging Clinics of North America
- Vol. 33 (2) , 331-350
MR Imaging of the Brachial Plexus
- 22 February 2025
- Published by Elsevier in Magnetic Resonance Imaging Clinics of North America
- Vol. 33 (2) , 331-350
MR Imaging of the Brachial Plexus